Mark Stejbach Flexion Therapeutics Inc (FLXN) insider trading activity
Mark Stejbach is Director of Flexion Therapeutics Inc. Currently has a direct ownership of 0 shares of FLXN, which is worth approximately $0. The most recent transaction as insider was on Nov 19, 2021, when has been sold 12,631 shares (Common Stock) at a price of $8.5 per share, resulting in proceeds of $107,364. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
MS
Mark Stejbach
Director
Burlington, MA